Work

Effect of IL-6 and related mediators on resistance to abiraterone acetate (abi) and enzalutamide (enza) in patients with metastatic castration-resistant prostate cancer (mCRPC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.7_suppl.296

Authors: Jacob J. Adashek, Haejung Won, Dayson Moreira, Priyanka Duttagupta, Przemyslaw Twardowski, Jeremy Jones, Marcin Kortylewski, Sumanta K. Pal

Institutions: City Of Hope National Medical Center, Beckman Research Institute, City of Hope

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920805239

Cites:

Cited by:

Related to: 10